Search Results

You are looking at 1 - 3 of 3 items for

  • Author: Vasilios G. Igoumenou x
Clear All Modify Search
Andreas F. Mavrogenis First Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, Greece

Search for other papers by Andreas F. Mavrogenis in
Google Scholar
PubMed
Close
,
Vasilios G. Igoumenou First Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, Greece

Search for other papers by Vasilios G. Igoumenou in
Google Scholar
PubMed
Close
,
Thekla Antoniadou First Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, Greece

Search for other papers by Thekla Antoniadou in
Google Scholar
PubMed
Close
,
Panayiotis D. Megaloikonomos First Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, Greece

Search for other papers by Panayiotis D. Megaloikonomos in
Google Scholar
PubMed
Close
,
George Agrogiannis Second Department of Pathology, National and Kapodistrian University of Athens, School of Medicine, Greece

Search for other papers by George Agrogiannis in
Google Scholar
PubMed
Close
,
Periklis Foukas Second Department of Pathology, National and Kapodistrian University of Athens, School of Medicine, Greece

Search for other papers by Periklis Foukas in
Google Scholar
PubMed
Close
, and
Sotirios G. Papageorgiou Second Department of Internal Medicine, Hematology Unit, National and Kapodistrian University of Athens, School of Medicine, Greece

Search for other papers by Sotirios G. Papageorgiou in
Google Scholar
PubMed
Close

  • Non-Langerhans cell histiocytosis (N-LCH) summarizes a group of rare diseases with different clinical presentations, pathogenesis and morphology. These include primary cutaneous N-LCH, cutaneous N-LCH with systemic involvement, and primary extracutaneous systemic forms with occasional cutaneous involvement.

  • The juvenile (JXG) and non-juvenile xanthogranuloma (N-JXG) family of histiocytoses are N-LCH: the JXG family consisting of the JXG (cutaneous), xanthoma disseminatum (cutaneous and systemic) and Erdheim-Chester disease (ECD; systemic); and the N-JXG family consisting of the solitary reticulohistiocytoma (cutaneous), multicentric reticulohistiocytosis (cutaneous and systemic) and Rosai-Dorfman disease (RDD; systemic).

  • ECD is a clonal disorder from the JXG family of N-LCH; RDD is a reactive proliferative entity from the non-juvenile xanthogranuloma family of N-LCH.

  • ECD and RDD N-LCH are rare disorders, which are difficult to diagnose, with multi-organ involvement including bone and systemic symptoms, and which respond to therapy in an unpredictable way.

  • The key to successful therapy is accurate identification at tissue level and appropriate staging. Patients should be observed and monitored in a long-term pattern. Prognosis depends on disease extent and the organs involved; it is generally good for RDD disease and variable for ECD.

Cite this article: EFORT Open Rev 2018;3:381-390. DOI: 10.1302/2058-5241.3.170047

Open access
Andreas F. Mavrogenis First Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, ATTIKON University Hospital, Athens, Greece

Search for other papers by Andreas F. Mavrogenis in
Google Scholar
PubMed
Close
,
Panayiotis D. Megaloikonomos First Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, ATTIKON University Hospital, Athens, Greece

Search for other papers by Panayiotis D. Megaloikonomos in
Google Scholar
PubMed
Close
,
Thekla Antoniadou First Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, ATTIKON University Hospital, Athens, Greece

Search for other papers by Thekla Antoniadou in
Google Scholar
PubMed
Close
,
Vasilios G. Igoumenou First Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, ATTIKON University Hospital, Athens, Greece

Search for other papers by Vasilios G. Igoumenou in
Google Scholar
PubMed
Close
,
Georgios N. Panagopoulos First Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, ATTIKON University Hospital, Athens, Greece

Search for other papers by Georgios N. Panagopoulos in
Google Scholar
PubMed
Close
,
Leonidas Dimopoulos First Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, ATTIKON University Hospital, Athens, Greece

Search for other papers by Leonidas Dimopoulos in
Google Scholar
PubMed
Close
,
Konstantinos G. Moulakakis Department of Vascular Surgery, National and Kapodistrian University of Athens, School of Medicine, ATTIKON University Hospital, Athens, Greece

Search for other papers by Konstantinos G. Moulakakis in
Google Scholar
PubMed
Close
,
George S. Sfyroeras Department of Vascular Surgery, National and Kapodistrian University of Athens, School of Medicine, ATTIKON University Hospital, Athens, Greece

Search for other papers by George S. Sfyroeras in
Google Scholar
PubMed
Close
, and
Andreas Lazaris Department of Vascular Surgery, National and Kapodistrian University of Athens, School of Medicine, ATTIKON University Hospital, Athens, Greece

Search for other papers by Andreas Lazaris in
Google Scholar
PubMed
Close

  • The lifetime risk for diabetic patients to develop a diabetic foot ulcer (DFU) is 25%. In these patients, the risk of amputation is increased and the outcome deteriorates.

  • More than 50% of non-traumatic lower-extremity amputations are related to DFU infections and 85% of all lower-extremity amputations in patients with diabetes are preceded by an ulcer; up to 70% of diabetic patients with a DFU-related amputation die within five years of their amputation.

  • Optimal management of patients with DFUs must include clinical awareness, adequate blood glucose control, periodic foot inspection, custom therapeutic footwear, off-loading in high-risk patients, local wound care, diagnosis and control of osteomyelitis and ischaemia.

Cite this article: EFORT Open Rev 2018;3:513-525. DOI: 10.1302/2058-5241.3.180010

Open access
Panagiotis T. Masouros Department of Orthopaedics, Evangelismos General Hospital, Athens, Greece

Search for other papers by Panagiotis T. Masouros in
Google Scholar
PubMed
Close
,
Emmanuel P. Apergis Korgialeneio Mpenakeio Hellenic Red Cross Hospital, Athens, Greece

Search for other papers by Emmanuel P. Apergis in
Google Scholar
PubMed
Close
,
George C. Babis Second Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Search for other papers by George C. Babis in
Google Scholar
PubMed
Close
,
Stylianos S. Pernientakis Korgialeneio Mpenakeio Hellenic Red Cross Hospital, Athens, Greece

Search for other papers by Stylianos S. Pernientakis in
Google Scholar
PubMed
Close
,
Vasilios G. Igoumenou First Department of Orthopaedics, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Vasilios G. Igoumenou in
Google Scholar
PubMed
Close
,
Andreas F. Mavrogenis First Department of Orthopaedics, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Andreas F. Mavrogenis in
Google Scholar
PubMed
Close
, and
Vasileios S. Nikolaou Second Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Search for other papers by Vasileios S. Nikolaou in
Google Scholar
PubMed
Close

  • Reconstruction of the central band of the interosseous membrane is an emerging procedure implemented in the treatment of longitudinal radioulnar dissociation (LRUD), usually in its chronic setting, after Essex-Lopresti injuries of the forearm.

  • There are no sufficient clinical data to support reconstruction of the central band of the interosseous membrane in acute LRUD injuries.

  • Clinical and cadaveric studies comparing autografts (palmaris longus, flexor carpi radialis and bone-patellar-bone), allografts (Achilles tendon) and synthetic ligaments have not shown superiority of one technique versus another; however, they have shown special concerns with respect to the use of synthetic grafts.

  • Latrogenic fracture, decrease of rotational range of movement, iatrogenic nerve injury (superficial radial and median nerve), donor site morbidity with autografts and recurrent instability are the complications reported in literature after interosseous membrane reconstruction.

Cite this article: EFORT Open Rev 2019;4:143-150. DOI: 10.1302/2058-5241.4.180072

Open access